| 1 | Liver Neoplasms, Experimental | 39% |
| 2 | Peritoneal Neoplasms | 30.3% |
| 3 | Gastrointestinal Neoplasms | 28.8% |
| 4 | Pancreatic Neoplasm | 27.1% |
| 5 | Cystadenoma | 26.1% |
| 6 | Mesothelioma | 26.1% |
| 7 | Esophageal Neoplasms | 22% |
| 8 | Adenomatosis, Pulmonary | 20.9% |
| 9 | Adenomatous Polyps | 20.9% |
| 10 | Carcinoma, Pancreatic Ductal | 20.8% |
| 11 | Adenoma, Acidophil | 20.4% |
| 12 | Bile Duct Neoplasms | 19.8% |
| 13 | gallbladder neoplasm | 19.8% |
| 14 | Intestinal Neoplasms | 19.8% |
| 15 | Stomach Neoplasms | 19.8% |
| 16 | insulinoma | 19.4% |
| 17 | Adenomatous Polyposis Coli | 18.7% |
| 18 | Neoplasms, Neuroepithelial | 18.7% |
| 19 | Gliomatosis cerebri | 18.7% |
| 20 | Basal cell carcinoma | 17.4% |
| 21 | Carcinoma, Papillary | 17.4% |
| 22 | Squamous cell carcinoma | 17.4% |
| 23 | Carcinoma, Basal Cell | 17.4% |
| 24 | Biliary cirrhosis | 17.3% |
| 25 | Zollinger-Ellison syndrome | 17% |
| 26 | Carcinoma, Lobular | 16.3% |
| 27 | Fatty Liver | 16% |
| 28 | Hepatitis | 16% |
| 29 | Portal Hypertension | 16% |
| 30 | Liver Cirrhosis | 16% |
| 31 | Focal Nodular Hyperplasia | 16% |
| 32 | Hepatic Insufficiency | 16% |
| 33 | Steatohepatitis | 16% |
| 34 | Carcinoma | 15.8% |
| 35 | Epithelioma | 15.8% |
| 36 | Colorectal Neoplasms | 15.6% |
| 37 | Acanthoma | 15.3% |
| 38 | Cystadenocarcinoma | 15.2% |
| 39 | Mucoepidermoid Carcinoma | 15.2% |
| 40 | Cecal Neoplasms | 15.1% |
| 41 | Duodenal Neoplasms | 15.1% |
| 42 | Gastrointestinal Stromal Tumors | 15% |
| 43 | Fatty Liver, Alcoholic | 15% |
| 44 | Hepatitis, Alcoholic | 15% |
| 45 | Liver Cirrhosis, Alcoholic | 15% |
| 46 | Vipoma | 14.9% |
| 47 | Gastrinoma | 14.9% |
| 48 | Glucagonoma | 14.9% |
| 49 | Prolactinoma | 14.5% |
| 50 | Growth Hormone-Secreting Pituitary Adenoma | 14.5% |
| 51 | Carcinoma, Ehrlich Tumor | 14.4% |
| 52 | Carcinoma, Lewis Lung | 14.4% |
| 53 | Medulloblastoma | 14.1% |
| 54 | Liver Diseases, Parasitic | 13.8% |
| 55 | Biliary Tract Diseases | 13.7% |
| 56 | Gastrointestinal Diseases | 13.7% |
| 57 | Pancreatic Diseases | 13.7% |
| 58 | Hepatic Veno-Occlusive Disease | 13.5% |
| 59 | Peliosis Hepatis | 13.5% |
| 60 | Hepatopulmonary Syndrome | 13.5% |
| 61 | Abdominal Neoplasms | 13.3% |
| 62 | Head and Neck Neoplasms | 13.3% |
| 63 | Hepatomegaly | 13.3% |
| 64 | leukemia | 13.3% |
| 65 | Neoplasms, Germ Cell and Embryonal | 13.3% |
| 66 | Soft Tissue Neoplasms | 13.3% |
| 67 | Thoracic Neoplasms | 13.3% |
| 68 | Germ Cell Cancer | 13.3% |
| 69 | Hepatic Vein Thrombosis | 13.2% |
| 70 | Liver Abscess | 13.2% |
| 71 | Budd-Chiari Syndrome | 13.2% |
| 72 | Esophageal and Gastric Varices | 13.2% |
| 73 | Neuroectodermal Tumors | 13.2% |
| 74 | Bowen's Disease | 13% |
| 75 | Ganglioneuroma | 13% |
| 76 | Glioma | 13% |
| 77 | Malignant Glioma | 13% |
| 78 | Choledochal Cyst | 12.6% |
| 79 | Appendiceal Neoplasms | 12.5% |
| 80 | Colonic Neoplasms | 12.5% |
| 81 | Rectal Neoplasms | 12.5% |
| 82 | Pancreatic Cyst | 12.4% |
| 83 | Hamartoma | 12.3% |
| 84 | Neoplasms, Hormone-Dependent | 12.3% |
| 85 | Neoplasms, Multiple Primary | 12.3% |
| 86 | Paraneoplastic Syndromes | 12.3% |
| 87 | Precancerous Conditions | 12.3% |
| 88 | Neoplasms, Second Primary | 12.3% |
| 89 | Meningioma | 12.3% |
| 90 | Multiple Endocrine Neoplasia | 12% |
| 91 | Liver Abscess, Amebic | 11.8% |
| 92 | Anus Neoplasms | 11.7% |
| 93 | Sigmoid Neoplasms | 11.7% |
| 94 | Chemical and Drug Induced Liver Injury | 11.7% |
| 95 | Endocrine Gland Neoplasms | 11.5% |
| 96 | Eye Neoplasms | 11.5% |
| 97 | Nervous System Neoplasms | 11.5% |
| 98 | Pancreatic Fistula | 11.5% |
| 99 | Hepatorenal Syndrome | 11.4% |
| 100 | Adenofibroma | 11.4% |
| 101 | Fibroadenoma | 11.4% |
| 102 | Carcinoma 256, Walker | 11.3% |
| 103 | Bone neoplasms | 11.2% |
| 104 | Skin Neoplasms | 11.2% |
| 105 | Hematologic Neoplasms | 11.2% |
| 106 | melanoma | 11.2% |
| 107 | Histiocytic Disorders, Malignant | 11.1% |
| 108 | Splenic Neoplasms | 11.1% |
| 109 | Carcinoid Tumor | 11.1% |
| 110 | Carcinosarcoma | 10.9% |
| 111 | Hemangiosarcoma | 10.9% |
| 112 | lymphangiosarcoma | 10.9% |
| 113 | Retinoblastoma | 10.7% |
| 114 | Choriocarcinoma | 10.6% |
| 115 | Paraneoplastic Encephalomyelitis | 10.6% |
| 116 | Hepatitis, Chronic | 10.5% |
| 117 | Liver Failure | 10.5% |
| 118 | Non-alcoholic Fatty Liver Disease | 10.5% |
| 119 | Chronic active hepatitis | 10.5% |
| 120 | Trophoblastic Neoplasms | 10.5% |
| 121 | Adenocarcinoma | 10.5% |
| 122 | Carcinoma in Situ | 10.5% |
| 123 | Carcinoma, Transitional Cell | 10.5% |
| 124 | Papilloma | 10.5% |
| 125 | Pseudomyxoma Peritonei | 10.5% |
| 126 | Papillomatosis | 10.5% |
| 127 | Carcinoma, Large Cell | 10.5% |
| 128 | Carcinoma, Small Cell | 10.5% |
| 129 | Leukemia, Experimental | 10.4% |
| 130 | Mammary Neoplasms, Experimental | 10.4% |
| 131 | Cyst | 10.3% |
| 132 | Neoplastic Processes | 10.3% |
| 133 | Neoplastic Syndromes, Hereditary | 10.3% |
| 134 | Pregnancy Complications, Neoplastic | 10.3% |
| 135 | Neoplasms, Experimental | 10.2% |
| 136 | Melanoma, Experimental | 10.2% |
| 137 | Astrocytoma | 10.1% |
| 138 | Ependymoma | 10.1% |
| 139 | oligodendroglioma | 10.1% |
| 140 | Ganglioglioma | 10.1% |
| 141 | gliosarcoma | 10.1% |
| 142 | Anaplastic astrocytoma | 10.1% |
| 143 | Anaplastic Oligodendroglioma | 10.1% |
| 144 | Parathyroid Neoplasms | 10.1% |
| 145 | Thyroid Neoplasm | 10.1% |
| 146 | Thyroid carcinoma | 10.1% |
| 147 | Barrett Esophagus | 10% |
| 148 | Porphyrias, Hepatic | 10% |
| 149 | Dermoid Cyst | 9.9% |
| 150 | Composite Lymphoma | 9.8% |
| 151 | Proctocolitis | 9.7% |
| 152 | Mesenteric vascular insufficiency | 9.6% |
| 153 | Esophageal Atresia | 9.5% |
| 154 | Intestinal Atresia | 9.5% |
| 155 | Lymphoma | 9.5% |
| 156 | Mesenteric Vascular Occlusion | 9.5% |
| 157 | Intestinal Fistula | 9.5% |
| 158 | Enterocutaneous Fistula | 9.5% |
| 159 | Thymoma | 9.4% |
| 160 | Leukemia, Plasma Cell | 9.3% |
| 161 | Basal Cell Nevus Syndrome | 9.3% |
| 162 | Malignant Carcinoid Syndrome | 9.2% |
| 163 | Leukemia, Radiation-Induced | 9.2% |
| 164 | Hepatitis, Animal | 9.1% |
| 165 | Hepatitis, Viral, Human | 9.1% |
| 166 | Hepatitis B, Chronic | 9% |
| 167 | Hepatitis C, Chronic | 9% |
| 168 | Dysentery | 8.8% |
| 169 | Enteritis | 8.8% |
| 170 | Enterocolitis | 8.8% |
| 171 | Esophagitis | 8.8% |
| 172 | Gastritis | 8.8% |
| 173 | Inflammatory Bowel Diseases | 8.8% |
| 174 | Liver Cirrhosis, Experimental | 8.8% |
| 175 | Cholecystolithiasis | 8.8% |
| 176 | Neoplasms, Radiation-Induced | 8.8% |
| 177 | Glioblastoma | 8.7% |
| 178 | Neuroblastoma | 8.7% |
| 179 | Glioblastoma Multiforme | 8.7% |
| 180 | Chondrosarcoma | 8.7% |
| 181 | Craniopharyngioma | 8.7% |
| 182 | leiomyosarcoma | 8.7% |
| 183 | liposarcoma | 8.7% |
| 184 | synovial sarcoma | 8.7% |
| 185 | Neuroectodermal Tumor, Melanotic | 8.7% |
| 186 | Angiomyolipoma | 8.7% |
| 187 | Clear Cell Sarcoma of Soft Tissue | 8.7% |
| 188 | Alveolar Soft Part Sarcoma | 8.7% |
| 189 | Neuroendocrine Tumors | 8.7% |
| 190 | Sarcoma, Myeloid | 8.7% |
| 191 | Digestive System Neoplasms | 8.6% |
| 192 | Sarcoma, Experimental | 8.5% |
| 193 | Duodenitis | 8.4% |
| 194 | Ileitis | 8.4% |
| 195 | Erosive Duodenitis | 8.4% |
| 196 | Tracheal Neoplasms | 8.4% |
| 197 | Neurilemmoma | 8.3% |
| 198 | Hutchinson's Melanotic Freckle | 8.3% |
| 199 | Melanoma, Amelanotic | 8.3% |
| 200 | Rectal Fistula | 8.1% |
| 201 | Anal Fistula | 8.1% |
| 202 | Ganglioneuroblastoma | 8% |
| 203 | Bile Duct Diseases | 8% |
| 204 | Cholelithiasis | 8% |
| 205 | Chylous Ascites | 8% |
| 206 | Esophageal Diseases | 8% |
| 207 | Gastroenteritis | 8% |
| 208 | Intestinal Diseases | 8% |
| 209 | Pancreatic Insufficiency | 8% |
| 210 | Pancreatitis | 8% |
| 211 | Pneumoperitoneum | 8% |
| 212 | Stomach Diseases | 8% |
| 213 | Ameloblastoma | 7.9% |
| 214 | Angiokeratoma | 7.9% |
| 215 | Chordoma | 7.9% |
| 216 | Hemangioma | 7.9% |
| 217 | hemangiopericytoma | 7.9% |
| 218 | Lymphangioma | 7.9% |
| 219 | Mesenchymoma | 7.9% |
| 220 | Nevus | 7.9% |
| 221 | Retroperitoneal Neoplasms | 7.9% |
| 222 | Teratoma | 7.9% |
| 223 | Hepatoblastoma | 7.9% |
| 224 | Mixed Tumor, Mullerian | 7.9% |
| 225 | Germinoma | 7.9% |
| 226 | Teratocarcinoma | 7.9% |
| 227 | Angiofibroma | 7.9% |
| 228 | Sarcoma | 7.9% |
| 229 | Liver Failure, Acute | 7.8% |
| 230 | End Stage Liver Disease | 7.8% |
| 231 | Adenoid Cystic Carcinoma | 7.8% |
| 232 | Adenocarcinoma, Clear Cell | 7.8% |
| 233 | Cholangiocarcinoma | 7.8% |
| 234 | Cervical Intraepithelial Neoplasia | 7.8% |
| 235 | Carcinoma, Ovarian Epithelial | 7.8% |
| 236 | Tuberous Sclerosis | 7.8% |
| 237 | Pancreatic Pseudocyst | 7.7% |
| 238 | Colitis | 7.7% |
| 239 | Duodenogastric Reflux | 7.7% |
| 240 | Leukemia L1210 | 7.7% |
| 241 | Leukemia P388 | 7.7% |
| 242 | Peptic Ulcer | 7.7% |
| 243 | Proctitis | 7.7% |
| 244 | Choledocholithiasis | 7.7% |
| 245 | Nephroblastoma | 7.6% |
| 246 | Fascioliasis | 7.6% |
| 247 | Optic Nerve Glioma | 7.6% |
| 248 | Fibrosarcoma | 7.6% |
| 249 | Osteosarcoma | 7.6% |
| 250 | Echinococcosis, Hepatic | 7.6% |
| 251 | Chemical and Drug Induced Liver Injury, Chronic | 7.5% |
| 252 | Reye Syndrome | 7.5% |
| 253 | Carcinoid Heart Disease | 7.3% |
| 254 | Multiple Endocrine Neoplasia Type 1 | 7.3% |
| 255 | Endometrial Stromal Sarcoma | 7.3% |
| 256 | Acoustic Neuroma | 7.3% |
| 257 | Liver neoplasms | 7.2% |
| 258 | Malignant Fibrous Histiocytoma | 7% |
| 259 | Pouchitis | 6.9% |
| 260 | Liver diseases | 6.8% |
| 261 | Anus, Imperforate | 6.7% |
| 262 | Erythroplasia | 6.7% |
| 263 | Follicular cyst | 6.7% |
| 264 | Gastrointestinal Hemorrhage | 6.7% |
| 265 | Hemoperitoneum | 6.7% |
| 266 | Mesenteric Panniculitis | 6.7% |
| 267 | Mouth Neoplasms | 6.7% |
| 268 | Mucocele | 6.7% |
| 269 | Panniculitis, Peritoneal | 6.7% |
| 270 | Peritonitis | 6.7% |
| 271 | Pilonidal Cyst | 6.7% |
| 272 | Thyroglossal Cyst | 6.7% |
| 273 | Central Nervous System Neoplasms | 6.7% |
| 274 | Synovial Cyst | 6.7% |
| 275 | Vascular Neoplasms | 6.7% |
| 276 | Peritoneal Fibrosis | 6.7% |
| 277 | Aberrant Crypt Foci | 6.7% |
| 278 | Encapsulating Peritoneal Sclerosis | 6.7% |
| 279 | Anorectal Malformations | 6.7% |
| 280 | Thymus Neoplasms | 6.7% |
| 281 | Testicular Neoplasms | 6.6% |
| 282 | Biliary Fistula | 6.6% |
| 283 | Gastric Fistula | 6.6% |
| 284 | Autoimmune hepatitis | 6.6% |
| 285 | Tuberculosis, Gastrointestinal | 6.6% |
| 286 | Genital Neoplasms, Female | 6.6% |
| 287 | Plasmacytoma | 6.6% |
| 288 | Peutz-Jeghers Syndrome | 6.6% |
| 289 | Appendicitis | 6.6% |
| 290 | Malignant histiocytosis | 6.6% |
| 291 | Thyroid Nodule | 6.6% |
| 292 | Breast Neoplasms, Male | 6.6% |
| 293 | Histiocytic sarcoma | 6.6% |
| 294 | Triple Negative Breast Neoplasms | 6.6% |
| 295 | Sarcoma 180 | 6.5% |
| 296 | Lymphomatoid Granulomatosis | 6.5% |
| 297 | Variegate Porphyria | 6.5% |
| 298 | Acute intermittent porphyria | 6.5% |
| 299 | Porphyria Cutanea Tarda | 6.5% |
| 300 | Crohn Disease | 6.5% |
| 301 | Duodenal Obstruction | 6.5% |
| 302 | Enterocolitis, Neutropenic | 6.5% |
| 303 | Necrotizing Enterocolitis | 6.5% |
| 304 | Massive Hepatic Necrosis | 6.5% |
| 305 | Klatskin Tumor | 6.5% |
| 306 | Lymphangioleiomyomatosis | 6.5% |
| 307 | Paraganglioma | 6.5% |
| 308 | Rhabdomyosarcoma | 6.5% |
| 309 | Giant Cell Tumor of Bone | 6.5% |
| 310 | Adrenocortical carcinoma | 6.5% |
| 311 | Nasopharyngeal carcinoma | 6.2% |
| 312 | Neurofibrosarcoma | 6.1% |
| 313 | Duodenal Ulcer | 6% |
| 314 | Peptic Ulcer Perforation | 6% |
| 315 | Gastric ulcer | 6% |
| 316 | Dermatofibrosarcoma | 5.9% |
| 317 | Dermatofibrosarcoma Protuberans | 5.9% |
| 318 | Hepatitis, Viral, Animal | 5.9% |
| 319 | Mesoblastic Nephroma | 5.8% |
| 320 | Renal Cell Carcinoma | 5.8% |
| 321 | Papillary Renal Cell Carcinoma | 5.8% |
| 322 | Adrenal Gland Neoplasms | 5.8% |
| 323 | Genital Neoplasms, Male | 5.8% |
| 324 | Uveal Neoplasms | 5.8% |
| 325 | Leukoplakia, Oral | 5.8% |
| 326 | Hepatitis E | 5.7% |
| 327 | Paraneoplastic Cerebellar Degeneration | 5.7% |
| 328 | Urologic Neoplasms | 5.7% |
| 329 | Hepatitis B | 5.7% |
| 330 | Hepatitis C | 5.7% |
| 331 | Hepatitis A | 5.7% |
| 332 | Sebaceous Gland Neoplasms | 5.7% |
| 333 | Spinal Neoplasms | 5.7% |
| 334 | Bone Marrow Neoplasms | 5.7% |
| 335 | Leukoplakia | 5.6% |
| 336 | Lymphocele | 5.6% |
| 337 | Zellweger Syndrome | 5.6% |
| 338 | Hepatic Encephalopathy | 5.6% |
| 339 | Hodgkin Disease | 5.6% |
| 340 | Lymphoma, Non-Hodgkin | 5.6% |
| 341 | Enterocolitis, Pseudomembranous | 5.6% |
| 342 | pseudomembranous colitis | 5.6% |
| 343 | Dysentery, Bacillary | 5.6% |
| 344 | Breast Cyst | 5.6% |
| 345 | Actinic keratosis | 5.6% |
| 346 | Mediastinal Cyst | 5.6% |
| 347 | Neoplasm Invasiveness | 5.6% |
| 348 | Neoplasm Metastasis | 5.6% |
| 349 | Neoplasm Recurrence, Local | 5.6% |
| 350 | Parovarian Cyst | 5.6% |
| 351 | Pericardial Cyst | 5.6% |
| 352 | Thymic Cyst | 5.6% |
| 353 | Carcinogenesis | 5.6% |
| 354 | Myxoid cyst | 5.6% |
| 355 | Metastasis | 5.6% |
| 356 | Carcinoma, Endometrioid | 5.5% |
| 357 | Pheochromocytoma | 5.4% |
| 358 | Alveolar rhabdomyosarcoma | 5.4% |
| 359 | Cecal Diseases | 5.3% |
| 360 | Cholangitis | 5.3% |
| 361 | Cholecystitis | 5.3% |
| 362 | Cholestasis | 5.3% |
| 363 | Colonic Diseases | 5.3% |
| 364 | Common Bile Duct Diseases | 5.3% |
| 365 | Esophageal Stenosis | 5.3% |
| 366 | Ileal Diseases | 5.3% |
| 367 | Intestinal Obstruction | 5.3% |
| 368 | Intestinal Perforation | 5.3% |
| 369 | Jejunal Diseases | 5.3% |
| 370 | Pneumatosis Cystoides Intestinalis | 5.3% |
| 371 | Rectal Diseases | 5.3% |
| 372 | Gastric Dilatation | 5.3% |
| 373 | Pancreatitis, Chronic | 5.3% |
| 374 | Gastric outlet obstruction | 5.3% |
| 375 | Cronkhite-Canada Syndrome | 5.3% |
| 376 | Intestinal Polyposis | 5.3% |
| 377 | Hepatolenticular Degeneration | 5.2% |
| 378 | Phyllodes Tumor | 5.2% |
| 379 | Dysgerminoma | 5.2% |
| 380 | Hemangioendothelioma | 5.2% |
| 381 | Lipoma | 5.2% |
| 382 | Myoma | 5.2% |
| 383 | Myxoma | 5.2% |
| 384 | Neuroma | 5.2% |
| 385 | Seminoma | 5.2% |
| 386 | Angiolipoma | 5.2% |
| 387 | Myelolipoma | 5.2% |
| 388 | Neoplasms, Bone Tissue | 5.2% |
| 389 | Neoplasms, Fibrous Tissue | 5.2% |
| 390 | Smooth Muscle Tumor | 5.2% |
| 391 | Desmoplastic Small Round Cell Tumor | 5.2% |
| 392 | Chondroma | 5.2% |
| 393 | Enchondroma | 5.2% |
| 394 | granulosa cell tumor | 5.2% |
| 395 | Colitis, Ischemic | 5.2% |
| 396 | Colonic Pseudo-Obstruction | 5.1% |
| 397 | Cystic Fibrosis | 5.1% |
| 398 | Limbic Encephalitis | 5.1% |
| 399 | Congenital Hyperinsulinism | 5% |
| 400 | Leydig Cell Tumor | 5% |
| 401 | Primary amyloidosis | 4.9% |
| 402 | Hepatocellular Adenoma | 4.9% |
| 403 | Nose Neoplasms | 4.9% |
| 404 | Corpus Luteum Cyst | 4.7% |
| 405 | Ovarian Cysts | 4.7% |
| 406 | Lambert-Eaton Myasthenic Syndrome | 4.7% |
| 407 | Hydatidiform Mole | 4.6% |
| 408 | Palatal Neoplasms | 4.6% |
| 409 | Esophageal Perforation | 4.5% |
| 410 | Intestinal Diseases, Parasitic | 4.5% |
| 411 | Pituitary Adenoma | 4.5% |
| 412 | Pituitary Neoplasms | 4.5% |
| 413 | Deglutition Disorders | 4.4% |
| 414 | ovarian neoplasm | 4.4% |
| 415 | Achlorhydria | 4.4% |
| 416 | Gastric Antral Vascular Ectasia | 4.4% |
| 417 | Meningeal Neoplasms | 4.4% |
| 418 | Peptic Ulcer Hemorrhage | 4.4% |
| 419 | Gastroparesis | 4.4% |
| 420 | Pancreatitis, Alcoholic | 4.4% |
| 421 | Leukemia, Myelomonocytic, Chronic | 4.3% |
| 422 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 4.3% |
| 423 | Opsoclonus-Myoclonus Syndrome | 4.2% |
| 424 | Waldenstrom Macroglobulinemia | 3.9% |
| 425 | Multiple Myeloma | 3.9% |
| 426 | Cholestasis, Extrahepatic | 3.9% |
| 427 | Biliary Dyskinesia | 3.9% |
| 428 | Cholangitis, Sclerosing | 3.9% |
| 429 | Colonic Diseases, Functional | 3.9% |
| 430 | Esophageal motility disorders | 3.9% |
| 431 | Fecal Incontinence | 3.9% |
| 432 | Fecal Impaction | 3.9% |
| 433 | Intussusception | 3.9% |
| 434 | Mallory-Weiss Syndrome | 3.9% |
| 435 | Megacolon | 3.9% |
| 436 | Pyloric Stenosis | 3.9% |
| 437 | Acalculous Cholecystitis | 3.9% |
| 438 | Ileus | 3.9% |
| 439 | Meconium ileus | 3.9% |
| 440 | fibroma | 3.9% |
| 441 | Fibromatosis | 3.9% |
| 442 | Osteoblastoma | 3.9% |
| 443 | Osteoma | 3.9% |
| 444 | Rhabdomyoma | 3.9% |
| 445 | Chondromatosis | 3.9% |
| 446 | Hemangioblastoma | 3.9% |
| 447 | Lymphoma, Extranodal NK-T-Cell | 3.9% |
| 448 | Ear Neoplasms | 3.8% |
| 449 | Eyelid Neoplasms | 3.8% |
| 450 | Lung Neoplasms | 3.8% |
| 451 | Pleural Neoplasms | 3.8% |
| 452 | Myelitis, Transverse | 3.8% |
| 453 | Denys-Drash Syndrome | 3.8% |
| 454 | Mastocytosis | 3.8% |
| 455 | Melena | 3.8% |
| 456 | Sturge-Weber Syndrome | 3.8% |
| 457 | Brain Neoplasms | 3.8% |
| 458 | Salivary Gland Neoplasms | 3.8% |
| 459 | Spinal Cord Neoplasms | 3.8% |
| 460 | Tongue Neoplasms | 3.8% |
| 461 | Hemangioma, Cavernous | 3.7% |
| 462 | Hematemesis | 3.7% |
| 463 | Leukemia, T-Cell | 3.7% |
| 464 | Uterine Neoplasms | 3.7% |
| 465 | Vaginal Neoplasms | 3.7% |
| 466 | Vulvar Neoplasms | 3.7% |
| 467 | Uterine Cancer | 3.7% |
| 468 | Leukemia, B-Cell | 3.7% |
| 469 | Fallopian Tube Neoplasms | 3.7% |
| 470 | neurofibroma | 3.7% |
| 471 | Lymphoma, Follicular | 3.7% |
| 472 | T-Cell Lymphoma | 3.7% |
| 473 | Mantle cell lymphoma | 3.7% |
| 474 | Pharyngeal Neoplasms | 3.4% |
| 475 | Rift Valley Fever | 3.3% |
| 476 | Neoplasms, Glandular and Epithelial | 3.3% |
| 477 | Central Nervous System Cysts | 3.3% |
| 478 | Hemorrhoids | 3.3% |
| 479 | Penile Neoplasms | 3.3% |
| 480 | Prostatic Neoplasms | 3.3% |
| 481 | Afferent Loop Syndrome | 3.3% |
| 482 | Celiac Disease | 3.3% |
| 483 | Lymphatic Metastasis | 3.3% |
| 484 | Neoplasms, Unknown Primary | 3.3% |
| 485 | Short Bowel Syndrome | 3.3% |
| 486 | Sprue, Tropical | 3.3% |
| 487 | Steatorrhea | 3.3% |
| 488 | Rectocele | 3.3% |
| 489 | Leukemic Infiltration | 3.3% |
| 490 | Sprue | 3.3% |
| 491 | Neoplasm Micrometastasis | 3.3% |
| 492 | Mastocytoma | 3.3% |
| 493 | Nesidioblastosis | 3.3% |
| 494 | Diverticulitis | 3.3% |
| 495 | Dumping Syndrome | 3.3% |
| 496 | Rectal Prolapse | 3.3% |
| 497 | Esophageal Achalasia | 3.3% |
| 498 | Anal Fissure | 3.3% |
| 499 | Intestinal Pseudo-Obstruction | 3.3% |
| 500 | Irritable Bowel Syndrome | 3.3% |
| 501 | Superior Mesenteric Artery Syndrome | 3.3% |
| 502 | Emphysematous Cholecystitis | 3.3% |
| 503 | Neurogenic Bowel | 3.3% |
| 504 | Sphincter of Oddi Dysfunction | 3.3% |
| 505 | Anal Ulcer | 3.3% |
| 506 | Polycythemia Vera | 3.3% |
| 507 | Fibromatosis, Aggressive | 3.3% |
| 508 | Fibromatosis, Abdominal | 3.3% |
| 509 | Meningeal Carcinomatosis | 3.3% |
| 510 | Mastocytosis, Systemic | 3.3% |
| 511 | Leukemia, Myeloid, Chronic-Phase | 3.2% |
| 512 | Laryngeal neoplasm | 3% |
| 513 | Bladder Neoplasm | 2.9% |
| 514 | Kidney Neoplasm | 2.9% |
| 515 | Ureteral Neoplasms | 2.9% |
| 516 | Urethral Neoplasms | 2.9% |
| 517 | Giardiasis | 2.9% |
| 518 | Bronchial Neoplasms | 2.8% |
| 519 | Diverticulum | 2.8% |
| 520 | Diverticulosis | 2.8% |
| 521 | Multiple Pulmonary Nodules | 2.8% |
| 522 | Polycystic Ovary Syndrome | 2.8% |
| 523 | Supratentorial Neoplasms | 2.8% |
| 524 | Xeroderma Pigmentosum | 2.8% |
| 525 | Endometrial Neoplasms | 2.8% |
| 526 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 2.8% |
| 527 | Leukemia, Large Granular Lymphocytic | 2.8% |
| 528 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 2.8% |
| 529 | Lymphoma, T-Cell, Cutaneous | 2.8% |
| 530 | Lymphoma, AIDS-Related | 2.8% |
| 531 | Enteropathy-Associated T-Cell Lymphoma | 2.8% |
| 532 | Primary Effusion Lymphoma | 2.8% |
| 533 | Pruritus Ani | 2.7% |
| 534 | Laryngopharyngeal Reflux | 2.5% |
| 535 | Hypopharyngeal Neoplasms | 2.5% |
| 536 | Pleural Effusion, Malignant | 2.5% |
| 537 | Hypopharyngeal Cancer | 2.5% |
| 538 | Lactose Intolerance | 2.4% |
| 539 | Parotid Neoplasms | 2.4% |
| 540 | Prostatic Neoplasms, Castration-Resistant | 2.4% |
| 541 | Nelson Syndrome | 2.4% |
| 542 | Dupuytren Contracture | 2.4% |
| 543 | Urticaria Pigmentosa | 2.3% |
| 544 | Brain Stem Neoplasms | 2.3% |
| 545 | Mycosis Fungoides | 2.3% |
| 546 | Lymphomatoid Papulosis | 2.3% |
| 547 | Plasmablastic lymphoma | 2.3% |
| 548 | Burkitt Lymphoma | 2.2% |
| 549 | Choroid Plexus Papilloma | 2.1% |
| 550 | Tonsillar Neoplasms | 2% |
| 551 | Cerebellar Neoplasms | 2% |
| 552 | Cryptosporidiosis | 2% |
| 553 | Nasopharyngeal Neoplasms | 2% |
| 554 | Adenoma | 2% |
| 555 | Cell Transformation, Viral | 1.9% |
| 556 | Sezary Syndrome | 1.8% |
| 557 | Paranasal Sinus Neoplasms | 1.8% |
| 558 | CREST Syndrome | 1.6% |
| 559 | Maxillary Sinus Neoplasms | 1.5% |
| 560 | Radicular Cyst | 0.9% |